Pillstats
Rx only · Capsule · Oral

Anagrelide

Anagrelide Hydrochloride

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01XX35
RxCUI (US)596724
US makers3 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.330$0.659$0.989$1.32Dec 2025Apr 2026Jul 2026
$1.098
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
3
Active US suppliers
75%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2595187761.0K2025 Q12025 Q22025 Q32025 Q42026 Q1
619
Rx · 2026 Q1
52K
Units dispensed
-24%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Torrent Pharmaceuticals Limitedunknown4SUPPLYING
ANI Pharmaceuticals, Inc.unknown2SUPPLYING
Chartwell RX, LLCunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 25, 2020
    RECALLRecall (Class I): Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ…

    Failed Dissolution Specifications — Recalling firm: Torrent Pharma Inc — Nationwide USA and Puerto Rico

  • Sep 6, 2019
    RECALLRecall (Class II): Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking R…

    Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing. — Recalling firm: Torrent Pharma Inc. — Nationwide in the USA and Puerto Rico